Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-21-009397)

Filing Details

Accession Number:: 0001127602-21-009397
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-04 16:13:20
Reporting Period:: 2021-03-02

Accepted Time:: 2021-03-04 16:13:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221127	M. Lori Henderson	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139	General Counsel And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-03-02	6,600	$25.93	7,501	No	4	M	Direct
Common Stock	Disposition	2021-03-02	6,600	$153.77	901	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-03-02	6,600	$0.00	6,600	$25.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
150,939	2021-02-28	2030-02-28	No	4	M	Direct

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
Includes 220 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on November 30, 2020.
25% of this option will vest and become exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.